We aim to foster a more transparent, collaborative and productive IP/innovation eco-system for India. Retweets are not endorsements.
India
Joined March 2011
- Tweets9.6K
- Following130
- Followers5.8K
- Likes633
Pinned Tweet
As we step into the new year, we thank our readers for their continued support and wish everyone a very happy and healthy year ahead.(5/5)
spicyip.com/2025/12/a-look-b…
As courts increasingly turn to AI tools for legal research and document processing, could hidden instructions embedded in pleadings manipulate the outputs they rely on? In this post, Rohit Pradhan examines the threat of prompt injection in judicial proceedings,... (1/2)
...distinguishes it from AI hallucinations, and proposes safeguards for e-filing systems and legal accountability in India. Rohit Pradhan is an IP litigator based in Delhi, practising before the Delhi High Court.
spicyip.com/2026/10/hidden-a… (2/2)
Recently, the Delhi High Court, in Niva Bupa v. Vishal Rattewal imposed Re. 1 in notional costs after finding the plaintiffs’ suit to be a “misuse” of the IPD’s special jurisdiction.
In this post, Aryan Agrawal examines whether the failure of a trademark infringement claim is sufficient to constitute such misuse, and whether the Court adequately considered the IPD Rules’ express inclusion of disparagement within its remit.
spicyip.com/2026/10/can-you-…
SpicyIP (spicyip.bsky.social) retweeted
The government and courts are expanding intellectual property protection over information goods—from drugs to generative AI—without empirical evidence. Invoking 'innovation' and 'global standards' instead of data, this expansion of rights with IP holders raises access costs and curbs competition. Bharathwaj Ramakrishnan writes @SpicyIP
theindiaforum.in/law/indias-…
A quick tidbit on the free online version of Feroz Ali’s treatise on patent law, interesting orders from various High Courts, and exciting national and international IP developments in this week’s SpicyIP Weekly Review. (1/2)
Anything we’ve missed? Drop a comment and let us know!
spicyip.com/2026/10/spicyip-… (2/2)
SpicyIP Weekly Review (October 12-October 18)
Here’s this week’s roundup of IP developments, from posts on the Kerala High Court’s Ribociclib decision under Section 100 of the Patents Act, the Delhi HC’s tiered approach to patent appeals in Esteve Pharmaceuticals, (1/2)
the PABS Annex of the WHO Pandemic Agreement, to key judicial decisions and national and international IP updates. Anything we missed out on? Drop a comment below to let us know!
spicyip.com/2026/10/spicyip-… (2/2)
Patent research often means working through lengthy judgments to find the reasoning that matters. Prof. Feroz Ali’s newly launched "Ali on Patents" aims to make this process easier, bringing together judicial decisions and doctrinal commentary in a free, online resource. (1/2)
Rishabh Upadhyay takes it for a spin to see how it works in practice and shares his thoughts below:-
spicyip.com/2026/10/spicyip-… (2/2)
In May 2025, WHO member states adopted the Pandemic Agreement, which cannot open for signature until its PABS Annex is finalised. Negotiations remain deadlocked over whether benefit sharing should be tied to pathogen data access. (1/2)
In this post, Rishabh Upadhyay examines the EU’s Hybrid Model, the African Group’s Federated Model, and KEI’s proposal to delink the two, arguing that KEI’s approach offers a more robust solution but requires one key fix.
spicyip.com/2026/10/equitabl… (2/2)
The Centre for Intellectual Property Rights (CIPR), Institute of Law, Nirma University is inviting submissions for the Journal of Intellectual Property Laws(JIPL), Volume X. The last date for submission is 30 November. (1/2)
For more details, read the call for submissions below :-
spicyip.com/2026/10/call-for… (2/2)
As Halloween approaches, a particular editorial at ET seems spooked by the prospect of lawful and equitable access to medicines! In doing the opposite of what its title suggests, ‘Protect Patients and Patents Smartly’, the editorial piece published on October 15, 2026 (1/3)
is an unfortunate example of legal misinformation and misinterpretation, stuck in the old binary of access versus patent. Ambika Aggarwal explains how this published piece runs contrary to years of judicial wisdom, contradicts itself, conflates different legal questions.. (2/3)
...and advocates for a rather shocking political consequence.
spicyip.com/2026/10/the-ghos… (3/3)
In Esteve Pharmaceuticals, the Delhi High Court found that a patent application lacked inventive step and declined to examine whether it also fell foul of the exclusions under Sections 3(d) and 3(e) of the Patents Act, invoking judicial economy. (1/2)
But does this approach get the sequence of patentability assessment right? Maneesha Gupta takes a closer look at the statutory scheme and examination guidelines and raises questions about whether the Court has put the cart before the horse.
spicyip.com/2026/10/putting-… (2/2)
